Skip to content

Prevalence, Persistence, and Risk Factors for Oral Human Papillomavirus (HPV) Infections in College Women

Prevalence, Persistence, and Risk Factors for Oral HPV Infections in College Women

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01289873
Acronym
HOP-IN
Enrollment
1036
Registered
2011-02-04
Start date
2011-05-31
Completion date
2012-09-30
Last updated
2013-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Papillomavirus

Brief summary

The purpose of this study is to determine how common oral HPV infections are in college women. The investigators also will find out what risk factors are associated with having oral HPV infections. The investigators hypothesize that approximately 3% of women will have oral HPV, and that HPV will be associated with oral sexual behaviors and with smoking behaviors. Finally, for those women with oral HPV- the investigators will determine whether the infections are persistent (still present) at 3-, 6-, and 12-months after the initial diagnosis.

Interventions

None listed

Sponsors

Merck Sharp & Dohme LLC
CollaboratorINDUSTRY
University of Florida
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age \>=18 years * Female * Currently enrolled as a college student

Exclusion criteria

* Unable to provide an oral rinse sample * Unable to complete survey * Unable to provide contact information * Already completed study.

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of oral HPVat enrollmentany oral HPV at enrollment

Secondary

MeasureTime frameDescription
Persistence of oral HPV over 1 year of follow-up1 yearDetermine whether HPV remains present at 3-months, 6-months, and 12-months after enrollment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026